Ashe Andrew D. sold Verve Therapeutics ($VERV) shares once on the open market in the last year for a total of $11,126, with the most recent sale on April 2, 2025. This ranks his sales volume 11,250th among 11,678 insiders, far below the average of 8.6 million per seller across 6.4 transactions. He made no open market purchases in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| July 25, 2025 | Verve Therapeutics, Inc. | $VERV | Ashe Andrew D. | See Remarks | U | Common Stock | 348828 | $0.00 | 0.0000 | 89,143,237 | 100.00% | 0.39% |
| July 25, 2025 | Verve Therapeutics, Inc. | $VERV | Ashe Andrew D. | See Remarks | D | Stock Option (right to buy) | 225000 | $0.00 | 0.0000 | 89,143,237 | 100.00% | 0.25% |
| July 25, 2025 | Verve Therapeutics, Inc. | $VERV | Ashe Andrew D. | See Remarks | D | Restricted Stock Units | 40000 | $0.00 | 0.0000 | 89,143,237 | 100.00% | 0.04% |
| July 25, 2025 | Verve Therapeutics, Inc. | $VERV | Ashe Andrew D. | See Remarks | D | Restricted Stock Units | 27000 | $0.00 | 0.0000 | 89,143,237 | 100.00% | 0.03% |
| July 25, 2025 | Verve Therapeutics, Inc. | $VERV | Ashe Andrew D. | See Remarks | D | Stock Option (right to buy) | 107997 | $0.00 | 0.0000 | 89,143,237 | 100.00% | 0.12% |
| July 25, 2025 | Verve Therapeutics, Inc. | $VERV | Ashe Andrew D. | See Remarks | D | Stock Option (right to buy) | 153278 | $0.00 | 0.0000 | 89,143,237 | 100.00% | 0.17% |
| July 25, 2025 | Verve Therapeutics, Inc. | $VERV | Ashe Andrew D. | See Remarks | D | Stock Option (right to buy) | 26999 | $0.00 | 0.0000 | 89,143,237 | 100.00% | 0.03% |
| July 25, 2025 | Verve Therapeutics, Inc. | $VERV | Ashe Andrew D. | See Remarks | D | Stock Option (right to buy) | 150000 | $0.00 | 0.0000 | 89,143,237 | 100.00% | 0.17% |
| April 1, 2025 | Verve Therapeutics, Inc. | $VERV | Ashe Andrew D. | See Remarks | M | Common Stock | 9000 | $0.00 | 351,509.0000 | 88,795,768 | 2.63% | 0.01% |
| April 2, 2025 | Verve Therapeutics, Inc. | $VERV | Ashe Andrew D. | See Remarks | S | Common Stock | 2681 | $4.15 | 348,828.0000 | 88,795,768 | 0.76% | 0.00% |
| April 1, 2025 | Verve Therapeutics, Inc. | $VERV | Ashe Andrew D. | See Remarks | M | Restricted Stock Units | 9000 | $0.00 | 27,000.0000 | 88,795,768 | 25.00% | 0.01% |
| Jan. 8, 2025 | Verve Therapeutics, Inc. | $VERV | Ashe Andrew D. | See Remarks | A | Stock Option (right to buy) | 225000 | $0.00 | 225,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 8, 2025 | Verve Therapeutics, Inc. | $VERV | Ashe Andrew D. | See Remarks | A | Restricted Stock Units | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| May 14, 2024 | Verve Therapeutics, Inc. | $VERV | Ashe Andrew D. | See Remarks | P | Common Stock | 76000 | $6.26 | 342,509.0000 | 0 | 28.52% | 0.00% |
| Feb. 14, 2024 | Verve Therapeutics, Inc. | $VERV | Ashe Andrew D. | See Remarks | A | Stock Option (right to buy) | 150000 | $0.00 | 150,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 14, 2024 | Verve Therapeutics, Inc. | $VERV | Ashe Andrew D. | See Remarks | A | Restricted Stock Units | 36000 | $0.00 | 36,000.0000 | 0 | 9999.99% | 0.00% |